Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype
- PMID: 9041685
- PMCID: PMC2588967
Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype
Abstract
Introduction: The neuroendocrine histamine-secreting cell of the gastric fundus, the enferochromaffin-like cell, is the principal regulator of parietal cell acid secretion. We have proposed that histamine may regulate its own synthesis and release via an autocrine mechanism. The purpose of this study was to evaluate the role of the histamine receptor subtypes H1, H2 and H3 in the regulation of this phenomenon.
Methods: Purified ECL cells were isolated by pronase digestion and EDTA exposure of the rat stomach, followed by particle size and density separation using counterflow elutriation and Nycodenz gradient centrifugation, 24-hr cultured cells were pretreated for 30 min with the agents; H1 receptor agonist (2-[(3-trimethyl)-diphenyl] histamine) (TMPH), H1 receptor antagonist (terfenadine); H2 receptor agonist (dimaprit) or antagonist (cimetidine or loxitidine); or H3 receptor agonist (imetit) or antagonist (thioperamide) (all tested, 10(-10)-10(-6) M). Gastrin was then used to stimulate histamine secretion. Histamine secretion was quantified by specific enzyme-immunoassay.
Results: Basal histamine secretion was 2.7 +/- 0.14 nmol/10(3) cells. Gastrin-stimulated (10 nM) levels were 4.6 +/- 0.4 nmol/10(3) cells (p < .01). TMPH inhibited both basal and gastrin driven histamine secretion with a maximal effect (34 percent) (1.78 +/- 0.08 nmol/10(3) cells) and an IC50 of > 5 x 10(-7) M. H1 receptor antagonism did not alter histamine secretion alone or in combination with gastrin. Neither H2 receptor stimulation nor antagonism had any effect on histamine secretion alone or in combination with gastrin. Gastrin-induced histamine secretion was dose-dependently inhibited by imetit (H3 agonist) with a maximal effect (2.4 +/- 0.6 nmol/10(3) cells) (p < .05) and an IC50 of 10(-9) M. Conversely, Thioperamide (H3 antagonist) dose-dependently augmented gastrin-stimulated histamine secretion with a maximum effect (5.7 +/- 0.5 nmol/10(3) cells) (p < .05) at 10(-8) M and an EC50 of 7 x 10(-10) M.
Conclusion: These data are consistent with the presence of an H3 receptor on the ECL cell which modulates gastrin-stimulated histamine secretion. Our observations support the proposal that a histamine-mediated short-loop autocrine regulatory mechanism of ECL cell secretion exists.
Similar articles
-
Regulation of mastomys ECL cell function by transforming growth factor alpha.J Surg Res. 1996 Feb 1;60(2):293-302. doi: 10.1006/jsre.1996.0046. J Surg Res. 1996. PMID: 8598657
-
Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.J Clin Invest. 1985 May;75(5):1679-89. doi: 10.1172/JCI111876. J Clin Invest. 1985. PMID: 2582001 Free PMC article.
-
Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.Ann R Coll Surg Engl. 1996 Mar;78(2):133-8. Ann R Coll Surg Engl. 1996. PMID: 8678447 Free PMC article.
-
Physiological significance of ECL-cell histamine.Yale J Biol Med. 1998 May-Aug;71(3-4):183-93. Yale J Biol Med. 1998. PMID: 10461351 Free PMC article. Review.
-
Role of histamine H3 receptors in the regulation of gastric functions.J Physiol Pharmacol. 2001 Dec;52(4 Pt 1):539-53. J Physiol Pharmacol. 2001. PMID: 11787757 Review.
Cited by
-
The expression and function of histamine H₃ receptors in pancreatic beta cells.Br J Pharmacol. 2014 Jan;171(1):171-85. doi: 10.1111/bph.12429. Br J Pharmacol. 2014. PMID: 24117016 Free PMC article.
-
Roles of histamine receptors and oxyradicals in aggravation of acid-induced gastric haemorrhagic ulcers in endotoxaemic rats.Inflammopharmacology. 1998;6(4):339-55. doi: 10.1007/s10787-998-0017-1. Inflammopharmacology. 1998. PMID: 17657630
-
Altered gastric chief cell lineage differentiation in histamine-deficient mice.Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1211-20. doi: 10.1152/ajpgi.90643.2008. Epub 2009 Apr 9. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19359424 Free PMC article.
-
New molecular targets for treatment of peptic ulcer disease.Drugs. 2003;63(17):1785-97. doi: 10.2165/00003495-200363170-00002. Drugs. 2003. PMID: 12921485 Review.
-
The life, achievements and legacy of a great Canadian investigator: Professor Boris Petrovich Babkin (1877-1950).Can J Gastroenterol. 2006 Sep;20(9):579-88. doi: 10.1155/2006/745853. Can J Gastroenterol. 2006. PMID: 17001399 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources